DCs cause a repressed cross-priming of CD8+ T cells adhered to tumor antigens following high levels of activated b-catenin; therefore, the entire process of anti-tumor immune response mediated by CD8+ T cell is dampened (30). This evidence concerns the gene CD8A and neoplasm.